Metallothionein-1+2 Deficiency Increases Brain Pathology in Transgenic Mice with Astrocyte-Targeted Expression of Interleukin 6
- 1 April 2002
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 9 (3) , 319-338
- https://doi.org/10.1006/nbdi.2002.0480
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Augmented Humoral Immune Function in Metallothionein-Null MiceToxicology and Applied Pharmacology, 2000
- Altered Central Nervous System Cytokine-Growth Factor Expression Profiles and Angiogenesis in Metallothionein-I+II Deficient MiceJournal of Cerebral Blood Flow & Metabolism, 2000
- Regulatory role of metallothionein in NF‐κB activationFEBS Letters, 1999
- Interactions of metallothionein with murine lymphocytes: plasma membrane binding and proliferationToxicology, 1996
- Immunomodulatory activities of extracellular metallothionein. II. effects on macrophage functionsJournal of Toxicology and Environmental Health, 1995
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- Immunomodulatory activities of extracellular metallothionein I. Metallothionein effects on antibody productionToxicology, 1993
- Development of a Competitive Double Antibody Radioimmunoassay for Rat MetallothioneinJournal of Immunoassay, 1993
- The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like proteinNeuron, 1991
- Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicalsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985